Funding for this research was provided by:
Department of Health, Government of Western Australia (Research Translation Project 2016 (Round 10))
Received: 13 July 2020
Accepted: 20 October 2020
First Online: 29 October 2020
Ethics approval and consent to participate
: Study investigators will ensure this trial is conducted in accordance with the principles of the Declaration of Helsinki [CitationRef removed] and with the ICH Guidelines for Good Clinical Practice [CitationRef removed].Ethics approval has been granted by Monash Health Human Research Ethics Committee (HREC/45334/MonH-2018-152902) and Western Australia Aboriginal Health Ethics Committee (868) Planned deviations from this protocol will not occur without approval from the relevant governing bodies. Informed consent will be documented in writing or electronically from all study participants.
: Not applicable.
: MH’s institute receives funding from Gilead Sciences, Abbvie and BMS for investigator-initiated research. AP has received an honoraria from Gilead Sciences unrelated to this work. WC’s institute has received funding from Merck & Co for investigator-initiated research. All other authors declare no financial or non-financial competing interests.